Practical Implications of GnrHa for PMDD for Health Care Professionals
Join Melissa Wagner, M.D., Ph.D., for a practical session on overcoming barriers to using GnRH agonists in treatment-resistant premenstrual dysphoric disorder. Designed for clinicians, this session will provide actionable strategies, along with ready-to-use patient and provider resources, screening tools, and treatment algorithms to support confident, evidence-based care.
Previous
PMDD: Clinical Implications, Neuroanatomical Hubs, and Substrates of Risk
Next